UnitedHealth Group is currently undervalued due to an overblown market reaction to profitability challenges. Click here to ...

UnitedHealth Group (UNH), once considered a reliable pillar in the managed care space, has suffered a stock decline of more ...

Disappointing second-quarter results from Elevance Health might not bode well for UnitedHealth Group. UnitedHealth Group ...

UnitedHealth's stock drop offers a rare value opportunity given recent acquisitions. UNH maintains industry-leading margins ...

Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by next year, the ...

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S.

UnitedHealth Group (UNH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports ...

Dodge & Cox Fund, an investment management company, released its “Dodge and Cox Stock Fund” second quarter 2025 investor ...

A career in health care is not for the faint of heart. We'll celebrate these heroes with an event and a special report in the ...

UnitedHealth Group Inc. (NYSE: UNH) is one of the most oversold S&P 500 stocks so far in 2025. While the stock was down only marginally in 2024, it has declined substantially in 2025, placing it among ...

The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy ...